Cat.#: ACPP-1555
| Despition | TGFBI Human Recombinant, 182 a.a. |
| SIZE | 10 µg |
| Purity | > 95.0% (SDS-PAGE) |
| Form | Sterile filtered liquid formulation. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1287 | Dopamine Receptor D1 Blocking Peptide (AC1287) | 250 µg | inquiry |
| ACPP-1348 | Presenilin 1 Blocking Peptide (AC1348) | 250 µg | inquiry |
| ACPP-1168 | KCNJ5 Blocking Peptide (AC1168) | 250 µg | inquiry |
| ACPP-1656 | Human MAPT Protein (AC1656) | 2 µg | inquiry |
| ACPP-1426 | Human ENO2 Protein (AC1426) | 5 µg | inquiry |
| ACPP-1804 | Human STMN2 Protein (AC1804) | 2 µg | inquiry |
| ACPP-1228 | Mouse IL 6 Protein (AC1228) | 2 µg | inquiry |
| ACPP-1172 | Native Human Prostate Specific Antigen (Functional) - Low endotoxin (AC1172) | 1 mg | inquiry |
| ACPP-1767 | Human YIF1B Protein (AC1767) | 5 µg | inquiry |
| ACPP-1205 | Human MECP2 Protein (AC1205) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.